Scientific Information on Symptoms of Alzheimer’s
Symptoms of Alzheimer’s
⚡ Try for FREE: Examine Personalized — easily stay on top of the latest research.
Summary of Symptoms of Alzheimer’s
Scientific Information on Symptoms of Alzheimer’s
📝 Don't fall for outdated information: Get Examine Personalized and acquire the latest research on 400+ supplements and their effects on 600+ health outcomes.
Already a member? Click here to login.
Human Effect Matrix
Unlocked for Examine membersThe Human Effect Matrix looks at human studies to tell you what supplements affect Symptoms of Alzheimer’s.
Full details on all Symptoms of Alzheimer’s supplements are available to Examine members.
| Grade | Level of Evidence [show legend] |
|---|---|
|
Robust research conducted with repeated double-blind clinical trials |
|
Multiple studies where at least two are double-blind and placebo controlled |
|
Single double-blind study or multiple cohort studies |
|
Uncontrolled or observational studies only |
|
Level of Evidence
?
The amount of high quality evidence. The more
evidence, the more we can trust the results.
|
Supplement |
Magnitude of effect
?
The direction and size of the supplement's impact on
each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
|
Consistency of research results
?
Scientific research does not always agree. HIGH or
VERY HIGH means that most of the scientific research agrees.
|
Notes |
|---|---|---|---|---|
|
|
Minor
|
Very High See all 5 studies |
Cognitive impairment that is associated with Alzheimer's appears to be significantly reduced with ginkgo supplementation.
|
|
|
|
Notable
|
- See study |
At least among nutraceuticals, Alpha-GPC appears to significantly improve cognition in persons with Alzheimer's disease at the dose of 1,200mg when taken as a daily supplement over a prolonged period of time.
|
|
|
|
Notable
|
Very High See 2 studies |
Very high dose Vitamin E supplementation in the form of α-tocopherol (2,000 IU) appears to reduce the rate of cognitive decline in persons with moderate to severe Alzheimer's Disease with a potency comparable to selegiline. Currently no research on lower (more standard) doses, and there appears to be no influence on minor AD or cognitive decline not characterized by AD.
|
|
|
|
||||
|
|
||||
|
|
||||
|
|
||||
Become an Examine Personalized member can access the latest nutrition research on over 400 supplements across over 600 different health goals, outcomes, conditions, and more.
Becoming an Examine subscriber not only unlocks the Human Effect Matrix for supplements, but also all health topics on Examine.com. We neatly summarize all the latest research so you can make the best decisions for your health based on what's accurate and not out-dated information.
Plus, you get a monthly summary of the latest research in the health topics you care about.
